Discover 236 paid clinical trials in Lebanon, New Hampshire. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Lebanon has about 15,000 residents and hosts the only National Cancer Institute designated comprehensive cancer centre in New Hampshire. Cancer research leads, including lung, ovarian, melanoma, and sarcoma studies, much of it run through the National Cancer Institute and cooperative groups, with epilepsy and inflammatory bowel disease the most visible non cancer areas.
Filter
2
Filter results
Results: 236
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Berlin Corners VT, Concord NH, Manchester NH,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT05642572
Phase2, Recruiting
Clinical Data Registry of Amblyopia Patients on Luminopia Treatment
for
Amblyopia
Location: Concord NH, Philadelphia PA, Indianapolis IN,
Sponsor: Luminopia
Sex: All
Age: 0+
Code: NCT06429280
Recruiting
Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer
for
Advanced Cancer, Metastatic Cancer
Location: Concord NH, Manchester NH, New York NY, Spartanburg SC,
Sponsor: Alliance Foundation Trials, LLC.
Sex: All
Age: 21+
Code: NCT06963723
Recruiting
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Concord NH, Manchester NH, Worcester MA, Hartford CT,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 0+
Code: NCT06031688
Phase2, Recruiting
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Location: Concord NH, Manchester NH, Sanford ME, Portsmouth NH,
Sponsor: American Society of Clinical Oncology
Sex: All
Age: 12+
Code: NCT02693535
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
for
Lung Non-Small Cell Carcinoma
Location: Concord NH, Manchester NH, Burlington MA, Worcester MA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06116682
Phase2, Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations